NEUROONE MED TECHNOLOGIES CO
NMTC·64130M209·US·Common Stock·Healthcare - Medical Devices-13D/G
NMTC (NEUROONE MED TECHNOLOGIES CO) is held by 15 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.1M), RENAISSANCE TECHNOLOGIES LLC ($508,954), GEODE CAPITAL MANAGEMENT, LLC ($478,075). Net institutional sentiment: Bearish.
15
Holders
Avg rating(6 Elite)
$2.5M
Total Value
28% (22)
Fund Consensus
5 buying - 13 selling
Who's Trading
ActivistBPBrian Pratt12.5%Jul 14, 2026
ActivistBPBrian Pratt7.4%Apr 21, 2026
InsiderCMChristianson MarkSell $11KMar 30, 2026
InsiderCMChristianson MarkSell $80Mar 13, 2026
InsiderCMChristianson MarkSell $653.6Mar 12, 2026
InsiderCMChristianson MarkSell $2KMar 11, 2026
InsiderCMChristianson MarkSell $9KMar 10, 2026
InsiderWJWambeke David J.Buy $670KMar 1, 2026
ActivistSISio Capital Management, LLC4.7%Nov 12, 2025
InsiderCMChristianson MarkSell $22KSep 5, 2025
13F: Insider & Congress:
Showing 1-20 of 22
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer